Here, we summarize the promising therapeutic targets for SLE therapy, which align with recent developments in understanding the diseases pathogenesis and the diversification of the SLE drug pipeline
The most commonly reported adverse effects are gastrointestinal in nature
Our findings suggest that, in clinical practice, escalating the semaglutide dose from 0.5 to 1.0 mg is associated with further improvements in glycemic control and weight loss
- when the patient receives any medication concomitantly which toxicity is increased due to hypokalemia like digoxin and neuromuscular blocking agents
The thigh offers a convenient, accessible injection site with adequate subcutaneous tissue for proper medication absorption
Behavioral changes associated with anxiety can include avoidance of social situations, changes in eating patterns beyond those intended for weight management, increased use of alcohol or other substances as coping mechanisms, and withdrawal from previously enjoyed activities